Alphatec Holdings, Inc. — Third Quarter 2026 Earnings Summary

Alphatec Holdings reported third-quarter 2026 total revenue of $221 million, representing a 13% year-over-year increase driven by a 14% rise in surgical revenue to $202 million. The company achieved a non-GAAP net income of $15 million and non-GAAP adjusted EBITDA of $38 million, while case volumes grew 20% and new surgeon adoption increased 25%. Despite the revenue growth, the company noted that biologics attachment was lower than expected, prompting a strategic focus on improving biologics performance. For the full year 2026, Alphatec now forecasts total revenue of approximately $862 million and adjusted EBITDA of approximately $137 million.